HRAS -Mutant Cardiomyocyte Model of Multifocal Atrial Tachycardia

Nelson A. Rodríguez, Nihir Patel, Rafael Dariolli, Simon Ng, Angelika G. Aleman, Jingqi Q.X. Gong, Hung Mo Lin, Matthew Rodríguez, Rebecca Josowitz, Katia Sol-Church, Karen W. Gripp, Xianming Lin, Soomin C. Song, Glenn I. Fishman, Eric A. Sobie, Bruce D. Gelb

Research output: Contribution to journalArticlepeer-review


BACKGROUND: Germline HRAS gain-of-function pathogenic variants cause Costello syndrome (CS). During early childhood, 50% of patients develop multifocal atrial tachycardia, a treatment-resistant tachyarrhythmia of unknown pathogenesis. This study investigated how overactive HRAS activity triggers arrhythmogenesis in atrial-like cardiomyocytes (ACMs) derived from human-induced pluripotent stem cells bearing CS-associated HRAS variants. METHODS: HRAS Gly12 mutations were introduced into a human-induced pluripotent stem cells-ACM reporter line. Human-induced pluripotent stem cells were generated from patients with CS exhibiting tachyarrhythmia. Calcium transients and action potentials were assessed in induced pluripotent stem cell-derived ACMs. Automated patch clamping assessed funny currents. HCN inhibitors targeted pacemaker-like activity in mutant ACMs. Transcriptomic data were analyzed via differential gene expression and gene ontology. Immunoblotting evaluated protein expression associated with calcium handling and pacemaker-nodal expression. RESULTS: ACMs harboring HRAS variants displayed higher beating rates compared with healthy controls. The hyperpolarization activated cyclic nucleotide gated potassium channel inhibitor ivabradine and the Nav1.5 blocker flecainide significantly decreased beating rates in mutant ACMs, whereas voltage-gated calcium channel 1.2 blocker verapamil attenuated their irregularity. Electrophysiological assessment revealed an increased number of pacemaker-like cells with elevated funny current densities among mutant ACMs. Mutant ACMs demonstrated elevated gene expression (ie, ISL1, TBX3, TBX18) related to intracellular calcium homeostasis, heart rate, RAS signaling, and induction of pacemaker-nodal-like transcriptional programming. Immunoblotting confirmed increased protein levels for genes of interest and suppressed MAPK (mitogen-activated protein kinase) activity in mutant ACMs. CONCLUSIONS: CS-associated gain-of-function HRASG12mutations in induced pluripotent stem cells-derived ACMs trigger transcriptional changes associated with enhanced automaticity and arrhythmic activity consistent with multifocal atrial tachycardia. This is the first human-induced pluripotent stem cell model establishing the mechanistic basis for multifocal atrial tachycardia in CS.

Original languageEnglish
Pages (from-to)E012022
JournalCirculation: Arrhythmia and Electrophysiology
Issue number4
StatePublished - 1 Apr 2024


  • Costello syndrome
  • heart rate
  • human
  • induced pluripotent stem cells
  • tachycardia


Dive into the research topics of 'HRAS -Mutant Cardiomyocyte Model of Multifocal Atrial Tachycardia'. Together they form a unique fingerprint.

Cite this